Incidence and outcomes of ductal carcinoma of the prostate in the USA

Analysis of data from the Surveillance, Epidemiology, and End Results program

Joshua J Meeks*, Lee C. Zhao, John Cashy, Shilajit D Kundu

*Corresponding author for this work

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

OBJECTIVE To use the national Surveillance, Epidemiology, and End Results (SEER) cancer registry to describe the natural history, national incidence and treatment patterns for ductal prostate cancer (PCa) over the last 20 years, as the available literature on ductal PCa is limited to small case series because of few patient numbers. PATIENTS AND METHODS From the SEER registry, 693 men with ductal PCa were identified from 1970. The demographics, clinical features and cause of death data were collected from men with ductal and acinar histological types. RESULTS The incidence of ductal PCa has increased over each decade, but the overall percentage of ductal relative to acinar PCa has remained stable. Men with ductal PCa were more likely to present with advanced disease (30% T3 with ductal PCa, compared with 7% with acinar PCa). Men with ductal PCa underwent similar rates of radical surgery, lower rates of radiotherapy but a higher frequency of outlet (transurethral resection) procedures. Men with ductal PCa had a significantly greater rate of death from PCa (12% vs 4%) than men with acinar PCa. Comparing PCa-specific mortality, men with ductal PCa had similar rates of death to men with Gleason 4 + 4 grade acinar PCa. CONCLUSIONS Despite a stable incidence, ductal PCa remains an aggressive PCa usually presenting with advanced clinical stage and resulting in a high rate of PCa-specific mortality similar to Gleason 4 + 4 acinar PCa. Patients would probably benefit from combined modalities including radical surgery, radiotherapy and palliative outlet procedures.

Original languageEnglish (US)
Pages (from-to)831-834
Number of pages4
JournalBJU International
Volume109
Issue number6
DOIs
StatePublished - Mar 1 2012

Fingerprint

SEER Program
Ductal Carcinoma
Prostate
Prostatic Neoplasms
Incidence
Mortality
Registries
Epidemiology
Radiotherapy

Keywords

  • incidence
  • pathology
  • prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this

@article{4e7540fe04ab405a97d46707049bdea8,
title = "Incidence and outcomes of ductal carcinoma of the prostate in the USA: Analysis of data from the Surveillance, Epidemiology, and End Results program",
abstract = "OBJECTIVE To use the national Surveillance, Epidemiology, and End Results (SEER) cancer registry to describe the natural history, national incidence and treatment patterns for ductal prostate cancer (PCa) over the last 20 years, as the available literature on ductal PCa is limited to small case series because of few patient numbers. PATIENTS AND METHODS From the SEER registry, 693 men with ductal PCa were identified from 1970. The demographics, clinical features and cause of death data were collected from men with ductal and acinar histological types. RESULTS The incidence of ductal PCa has increased over each decade, but the overall percentage of ductal relative to acinar PCa has remained stable. Men with ductal PCa were more likely to present with advanced disease (30{\%} T3 with ductal PCa, compared with 7{\%} with acinar PCa). Men with ductal PCa underwent similar rates of radical surgery, lower rates of radiotherapy but a higher frequency of outlet (transurethral resection) procedures. Men with ductal PCa had a significantly greater rate of death from PCa (12{\%} vs 4{\%}) than men with acinar PCa. Comparing PCa-specific mortality, men with ductal PCa had similar rates of death to men with Gleason 4 + 4 grade acinar PCa. CONCLUSIONS Despite a stable incidence, ductal PCa remains an aggressive PCa usually presenting with advanced clinical stage and resulting in a high rate of PCa-specific mortality similar to Gleason 4 + 4 acinar PCa. Patients would probably benefit from combined modalities including radical surgery, radiotherapy and palliative outlet procedures.",
keywords = "incidence, pathology, prostate cancer",
author = "Meeks, {Joshua J} and Zhao, {Lee C.} and John Cashy and Kundu, {Shilajit D}",
year = "2012",
month = "3",
day = "1",
doi = "10.1111/j.1464-410X.2011.10520.x",
language = "English (US)",
volume = "109",
pages = "831--834",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Incidence and outcomes of ductal carcinoma of the prostate in the USA

T2 - Analysis of data from the Surveillance, Epidemiology, and End Results program

AU - Meeks, Joshua J

AU - Zhao, Lee C.

AU - Cashy, John

AU - Kundu, Shilajit D

PY - 2012/3/1

Y1 - 2012/3/1

N2 - OBJECTIVE To use the national Surveillance, Epidemiology, and End Results (SEER) cancer registry to describe the natural history, national incidence and treatment patterns for ductal prostate cancer (PCa) over the last 20 years, as the available literature on ductal PCa is limited to small case series because of few patient numbers. PATIENTS AND METHODS From the SEER registry, 693 men with ductal PCa were identified from 1970. The demographics, clinical features and cause of death data were collected from men with ductal and acinar histological types. RESULTS The incidence of ductal PCa has increased over each decade, but the overall percentage of ductal relative to acinar PCa has remained stable. Men with ductal PCa were more likely to present with advanced disease (30% T3 with ductal PCa, compared with 7% with acinar PCa). Men with ductal PCa underwent similar rates of radical surgery, lower rates of radiotherapy but a higher frequency of outlet (transurethral resection) procedures. Men with ductal PCa had a significantly greater rate of death from PCa (12% vs 4%) than men with acinar PCa. Comparing PCa-specific mortality, men with ductal PCa had similar rates of death to men with Gleason 4 + 4 grade acinar PCa. CONCLUSIONS Despite a stable incidence, ductal PCa remains an aggressive PCa usually presenting with advanced clinical stage and resulting in a high rate of PCa-specific mortality similar to Gleason 4 + 4 acinar PCa. Patients would probably benefit from combined modalities including radical surgery, radiotherapy and palliative outlet procedures.

AB - OBJECTIVE To use the national Surveillance, Epidemiology, and End Results (SEER) cancer registry to describe the natural history, national incidence and treatment patterns for ductal prostate cancer (PCa) over the last 20 years, as the available literature on ductal PCa is limited to small case series because of few patient numbers. PATIENTS AND METHODS From the SEER registry, 693 men with ductal PCa were identified from 1970. The demographics, clinical features and cause of death data were collected from men with ductal and acinar histological types. RESULTS The incidence of ductal PCa has increased over each decade, but the overall percentage of ductal relative to acinar PCa has remained stable. Men with ductal PCa were more likely to present with advanced disease (30% T3 with ductal PCa, compared with 7% with acinar PCa). Men with ductal PCa underwent similar rates of radical surgery, lower rates of radiotherapy but a higher frequency of outlet (transurethral resection) procedures. Men with ductal PCa had a significantly greater rate of death from PCa (12% vs 4%) than men with acinar PCa. Comparing PCa-specific mortality, men with ductal PCa had similar rates of death to men with Gleason 4 + 4 grade acinar PCa. CONCLUSIONS Despite a stable incidence, ductal PCa remains an aggressive PCa usually presenting with advanced clinical stage and resulting in a high rate of PCa-specific mortality similar to Gleason 4 + 4 acinar PCa. Patients would probably benefit from combined modalities including radical surgery, radiotherapy and palliative outlet procedures.

KW - incidence

KW - pathology

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84857656924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857656924&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2011.10520.x

DO - 10.1111/j.1464-410X.2011.10520.x

M3 - Article

VL - 109

SP - 831

EP - 834

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 6

ER -